3 Beaten-Up Biotechs Bouncing Back In 2017
Published: Jul 24, 2017
Not every stock that falls on tough times is worth buying in portfolios, but sometimes, catalysts can spark shareholder-friendly rallies, and in those situations, it can make sense. For example, risk-tolerant investors might want to consider picking up shares in the beaten-up biotech stocks Zogenix (NASDAQ:ZGNX), Insys Therapeutics (NASDAQ:INSY), and Keryx Pharmaceuticals (NASDAQ:KERX). All three of these stocks are former highfliers, and each has catalysts that could help them regain some of their former glory.